SCHEMBL31350461

SCHEMBL31350461

CNc1nc(Cl)nc2nc(C)cc(C)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.42
KDM4E B2RXH2 7/20 0.39
ALDH1A1 P00352 7/20 0.39
HPGD P15428 6/20 0.39
CYP2C19 P33261 4/20 0.39
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 5/20 0.38
MAPT P10636 5/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
YTHDC1 Q96MU7 2/20 0.37
LMNA P02545 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
KMT2A Q03164 4/20 0.36
HTT P42858 3/20 0.36
RAD52 P43351 3/20 0.36
MITF O75030 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31350575 0.85 XDH (0.41) XDHKDM4EALDH1A1HPGDCYP2C19
SCHEMBL31350720 0.78 ALDH1A1 (0.40) KDM4EALDH1A1HPGDCYP2C19CYP1A2
SCHEMBL31350638 0.75 KDM4E (0.45) KDM4EALDH1A1HPGDCYP2C19CYP1A2
SCHEMBL31350459 0.72 ALDH1A1 (0.36) KDM4EALDH1A1HPGDCYP2C19CYP1A2
SCHEMBL31350904 0.69 NOS3 (0.36) XDHALDH1A1POLBMAPTCACNA1B
SCHEMBL31350551 0.67 CDC7 (0.35) XDHKDM4EALDH1A1HPGDMAPT
SCHEMBL31350703 0.67 ALDH1A1 (0.44) KDM4EALDH1A1HPGDCYP2C19CYP1A2
SCHEMBL31350697 0.66 ALDH1A1 (0.39) KDM4EALDH1A1HPGDCYP2C19CYP1A2
SCHEMBL11200698 0.66 ESR1 (0.57) XDHPOLBYTHDC1LMNAGAA
SCHEMBL12303081 0.65 ALDH1A1 (0.46) KDM4EALDH1A1HPGDCYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743462-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2026-05-20 EP disclosed
WO-2025012643-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2025-01-16 WO disclosed